| Table 2. Description of the study sample according to whether or not they have HyFoSy tubal patency (2 groups) No tubal patency = Bilateral tubal occlusion (n=5) + Unilateral tubal occlusion (n=15) Tubal patency = No tubal blockade (n=59) | |||||
| Tubal patency HyFoSy | |||||
|---|---|---|---|---|---|
| No (n=20) | Yes (n=59) | p-value | |||
| N | % | N | % | ||
| Age (years), Mean (SD) | 34.0 (4.1) | - | 33 (3.4) | - | 0.319* |
| BMI (kg/m2), Mean (SD) | 25.7 (4.4) | - | 25.1 (5.1) | - | 0.688* |
| Smoker No Yes Ex-Smoker |
13 5 2 |
65.0 25.0 10.0 |
46 9 3 |
79.3 15.5 5.2 |
0.429** |
| IgG Chlamydia Negative Positive |
15 5 |
75.0 25.0 |
53 6 |
89.8 10.2 |
0.098** |
| VAS HyFoSy intraprocedural, Mean (SD) | 5.4 (2.9) | - | 5.2 (2.2) | - | 0.791*** |
| VAS HyFoSy post-procedural, Mean (SD) | 3.1 (2.7) | - | 2.4 (2.4) | - | 0.280*** |
| Endometriosis No Yes |
18 2 |
90 10 |
58 1 |
98.3 1.7 |
0.156**** |
| Infertility time (months)1, Mean (SD) | 26.6 (15.5) | - | 26.3 (15.9) | - | 0.784*** |
| AMH (ng/mL) < 0,6 0.6 - 1.1 > 1.1 |
0 1 18 |
0.0 5.3 94.7 |
3 5 50 |
5.2 8.6 86.2 |
0.520** |
| Ovarian pathology No Yes2 |
18 2 |
90.0 10.0 |
56 3 |
94.9 5.1 |
0.596**** |
| Pelvic inflammatory disease history No Yes |
19 1 |
95.0 5.0 |
59 0 |
100 0.0 |
0.253**** |
| Antral follicle count < 10 10 - 20 > 20 |
1 7 12 |
5.0 35.0 60.0 |
9 21 29 |
15.3 35.6 49.2 |
0.453** |
| Soldo Programme No Yes |
4 16 |
20.0 80.0 |
20 39 |
33.9 66.1 |
0.277**** |
AMH: anti-Müllerian hormone, BMI: body mass index, SD: Standard Deviation, VAS: visual analogue scale.
1
Only for patients who do not belong to the SOLDO programme.
2 Type of ovarian pathology: Without tubal patency: Endometrioma (2); With bilateral tubal patency: Endometrioma (1) and Cyst (2).
T test / **χ2 test / ***Mann-Whitney test / ****Fisher’s exact test
Soldo: Soldo in Catalonia: Access to ART for women without a male partner